Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD200R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYP8B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF805 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PICSAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZMYM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF32-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRAGB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAP43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMSN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAS2R4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAML2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01122 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on